Delivery Order SPE2DB22D9239-SPE2DB25FDE20

Award Date 10/28/24
Potential Completion Date 11/19/24
Potential Value $96K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,131.04 firm fixed-price contract is for the delivery of Keytruda 100 mg/4 ml vials. This order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $96,342.84 contract is to provide 4566606893 - KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty oncology medication, to support the medical supply needs of military healthcare facilities. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA,...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $48,131.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 mL vials with a completion date of June 6, 2024. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, that enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $98,274.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract covers the supply of Keytruda 100 mg/4 ml vials, a specialty oncology medication, to support the recurring medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a $59,528.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Keytruda 100 mg/4 ml vials and has an ultimate completion date of April 26, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $32,087.36, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Keytruda, a cancer immunotherapy drug, with a completion date of May 28, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a $120,428.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999 that the DLA has with DMS Pharmaceutical Group to provide a wide range of pharmaceutical products and medical supplies to military health facilities worldwide. This delivery order is for the...
The U.S. Defense Logistics Agency (DLA) has awarded a $77,505.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,560,580,827 units of Keytruda 100 mg/4 ml vial, a cancer medication, with a performance period ending on May 3, 2023. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $48,131.04, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vials by May 9, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $100,273.00 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of April 29, 2024, is for the delivery of Keytruda 100 mg/4 ml vials. This delivery order is part of a larger indefinite delivery contract (SPE2DB) between DMS Pharmaceutical Group and DLA, valued up to $4,999,999 through 2025, for a...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDE20
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $96,262.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 ml vial, a specialized oncology medication. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities nationwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/2/25, 12:09 AM